Omnicell Names Nnamdi Njoku President to Advance AI and Growth Strategy

Nnamdi Njoku has been appointed President of healthcare technology company Omnicell, effective July 1, while retaining his role as Chief Operating Officer (COO), as the company strengthens its leadership team to support its AI platform strategy and long-term growth.

Randall Lipps will continue serving as CEO and Chairman, with a greater focus on strategic collaborations and the long-term evolution of Omnicell's portfolio. Njoku will oversee the company's growth strategy, innovation roadmap, and global operations while continuing to lead product execution and customer experience initiatives.

The appointment comes as healthcare technology companies continue investing in AI-powered platforms to improve hospital operations, medication safety, and clinical workflows. Broader developments in healthcare AI have highlighted how providers are increasingly embedding AI into clinical and operational systems rather than deploying standalone tools.

Expanded Leadership Role Centers on AI Platform

In his expanded role, Njoku will continue leading several of Omnicell's highest-profile initiatives, including the rollout of the Omnicell Titan XT automated dispensing system and the expansion of OmniSphere, the company's cloud-native software platform. Omnicell introduced Titan XT in late 2025 as its next-generation automated dispensing system built to work with OmniSphere, which connects medication management workflows across healthcare organizations.